Rocket Pharmaceuticals Inc. RCKT
$2.83
▲ +3.38% 24H
About
Rocket Pharmaceuticals Inc. is a late-stage biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company employs a multi-platform approach utilizing both adeno-associated viral (AAV) and lentiviral vector (LV) technologies to address genetic disorders with signific…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees299
TickerRCKT
Statistics
Market Cap$308.3M
Revenue (TTM)$0
Net Income-$223.1M
Net Margin—
EPS$-2.01
P/E-1.37
P/S—
P/B1.22
EV/EBITDA-0.81
ROE-64.4%
Dividend Yield—
Price$2.83
Data: Twelve Data · Revenue = mcap / P/S